StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

DMRA — Damora Therapeutics, Inc.

FAIR (MOS +4.7%) · Quality 4/100

Value Score 30 days ago: 12.4 → today 8.2

Price
23.25
Intrinsic value
24.4
Margin of safety
+4.7%
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
8.2
Quality
4
Psychology
19.8
Discovery
11
price/volume attention only
Moat score
0
erosion: none

Value Score: bottom 8% of Russell 3000 · Quality: bottom 6%

Open the interactive Deep Dive for DMRA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/DMRA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is DMRA undervalued?

As of 2026-11-11, DMRA trades at 23.25 against a computed intrinsic value of 24.4 (+4.7% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Damora Therapeutics, Inc.'s Value Score?

Damora Therapeutics, Inc.'s Value Score is 8.2 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.